🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. indocyanine green

    INDOCYANINE GREEN

    INJECTION FDA: approved

  2. indomethacin sodium

    INDOMETHACIN SODIUM

    INJECTION FDA: approved

  3. inebilizumab-cdon

    UPLIZNA

    INJECTION FDA: approved

  4. infigratinib phosphate

    TRUSELTIQ

    ORAL FDA: approved

  5. infliximab-abda

    RENFLEXIS

    INJECTION FDA: approved

  6. infliximab-axxq

    AVSOLA

    INJECTION FDA: approved

  7. infliximab-dyyb

    ZYMFENTRA

    INJECTION FDA: approved

  8. infliximab-qbtx

    IXIFI

    INJECTION FDA: approved

  9. influenza mrna vaccine

    MCOMBRIAX Teva Pharma GmbH

    EMA: approved

    J07B

  10. influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    PANDEMRIX

    EMA: unknown

    J07BB02

  11. influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)

    CELVAPAN

    EMA: withdrawn

    J07BB01

  12. influenza vaccine (live attenuated, nasal)

    FLUENZ TETRA

    EMA: approved

    J07BB03

  13. influenza vaccine (split virion, inactivated)

    INTANZA

    EMA: withdrawn

    J07BB02

  14. influenza vaccine (surface antigen, inactivated, adjuvanted)

    FLUAD TETRA

    EMA: approved

    J07BB02

  15. influenza vaccine (surface antigen, inactivated, prepared in cell cultures)

    FLUCELVAX

    EMA: approved

    J07BB02

  16. influenza vaccine h1n1v (surface antigen, inactivated, adjuvanted)

    FOCETRIA

    EMA: unknown

    J07BB02

  17. ingenol mebutate

    PICATO

    TOPICAL FDA: approved · EMA: withdrawn

    D06BX02

  18. inotersen sodium

    TEGSEDI

    SUBCUTANEOUS FDA: approved

  19. inotuzumab ozogamicin

    BESPONSA Pfizer Australia Pty Ltd

    FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    L01FB01

  20. insulin aspart

    FIASP PENFILL NovoThirteen

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved

    A10AB05

  21. insulin aspart + insulin aspart protamine

    NOVOMIX 30 FLEXPEN NovoThirteen

    TGA: approved

  22. insulin aspart protamine recombinant

    NOVOLOG MIX 50/50

    SUBCUTANEOUS FDA: approved

  23. insulin aspart recombinant

    NOVOLOG PENFILL

    SUBCUTANEOUS FDA: approved

  24. insulin aspart-szjj

    MERILOG

    SOLUTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources